Sort
21,281 grants matching “influenza”
AOU Community Engagement
$763,884Tania P Bardyn · University Of Washington · UG4 · FY2019 · LM
Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases
$763,801Thirumala-Devi Kanneganti · St. Jude Children'S Research Hospital · R01 · FY2022 · AI
Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases
$763,801Thirumala-Devi Kanneganti · St. Jude Children'S Research Hospital · R01 · FY2023 · AI
Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases
$763,801Thirumala-Devi Kanneganti · St. Jude Children'S Research Hospital · R01 · FY2021 · AI
Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases
$763,801Thirumala-Devi Kanneganti · St. Jude Children'S Research Hospital · R01 · FY2024 · AI
Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases
$763,801Thirumala-Devi Kanneganti · St. Jude Children'S Research Hospital · R01 · FY2025 · AI
Predictive Modeling of Estradiol Effects and Sex Differences on Immunopathology during Influenza Infection
$763,312Jason Edward Shoemaker · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Role of intracellular organelle homeostasis in adaptation to dietary restrictive interventions
$763,308Michael Sack · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults
$762,973John F Alcorn · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Epitope focusing by molecular grafting of subdominant epitopes to achieve a universal-influenza vaccine
$762,966Aaron Gregory Schmidt · Massachusetts General Hospital · R01 · FY2021 · AI
Epitope focusing by molecular grafting of subdominant epitopes to achieve a universal-influenza vaccine
$762,966Aaron Gregory Schmidt · Massachusetts General Hospital · R01 · FY2022 · AI
Epitope focusing by molecular grafting of subdominant epitopes to achieve a universal-influenza vaccine
$762,966Aaron Gregory Schmidt · Massachusetts General Hospital · R01 · FY2023 · AI
Inborn errors of immunity in patients with life-threatening COVID-19
$762,750Jean-Laurent Casanova · Rockefeller University · R01 · FY2021 · AI
Bi-functional Polymer-Attached Inhibitors of Influenza Viruses
$762,729Jianzhu Chen · Massachusetts Institute Of Technology · U01 · FY2010 · AI
Regional Centers for Public Health Preparedness and Response HDPTP
$762,673Janelle Rios · University Of Texas Hlth Sci Ctr Houston · U45 · FY2025 · ES
Development of a Multi-species Vaccine for Prevention of Bacterial Otitis Media
$762,572Charles C. McOsker · Clarametyx Bioscience, Inc. · R44 · FY2023 · DC
VTEU: Phase I Influenza Vaccine Clinical Trial
$762,539David Bernstein · Cincinnati Childrens Hosp Med Ctr · N01 · FY2016 · AI
The VesiVax® System: Vaccine Development Made Easy
$762,253Samon Ho · Molecular Express, Inc. · R44 · FY2016 · AI
Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness Decisions
$762,178Frederick R Haselton · Vanderbilt University · R01 · FY2024 · AI
Software Development & Core Facilities
$762,139Alessandro Vespignani · Fred Hutchinson Cancer Research Center · U54 · FY2018 · GM
Improving predictive capacity of models for universal influenza vaccine development
$762,129Richard John Webby · St. Jude Children'S Research Hospital · R01 · FY2023 · AI
Software Development & Core Facilities
$762,109Alessandro Vespignani · Fred Hutchinson Cancer Research Center · U54 · FY2017 · GM
Software Development & Core Facilities
$762,091Alessandro Vespignani · Fred Hutchinson Cancer Research Center · U54 · FY2016 · GM
A chikungunya Viral Replicon as a Platform for Antiviral Therapeutics
$762,045David E. Levy · Columbia University Health Sciences · U54 · FY2013 · AI
Mechanisms of BNT162b2 Vaccine Immunogenicity in Systemic Lupus Erythematosus or Scleroderma
$762,036Paul Joseph Utz · Stanford University · R01 · FY2024 · AI